https://www.pharmanow.live/latest-news/artelo-biosciences-art2713-glp1-combination-weight-loss-nonclinical-data 2026-11-13T11:54:15+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Artelo Reports 40% Weight Loss with Semaglutide in Mice Artelo https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/artelo-art2713-semaglutide-glp1-combination-weight-loss20261113115341.webp https://www.pharmanow.live/latest-news/grace-therapeutics-dual-source-cmo-strategy-gtx-104-nda-resubmission 2026-11-13T11:43:52+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Grace Therapeutics Advances Dual-Source CMO Strategy Grace https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/grace-therapeutics-gtx-104-dual-source-cmo-strategy20261113114236.webp https://www.pharmanow.live/latest-news/monopar-therapeutics-rolling-nda-submission-alxn1840-wilson-disease 2026-11-13T11:36:01+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Monopar Therapeutics Nears Rolling NDA Completion for ALXN1840 Monopar Therapeutics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/monopar-therapeutics-alxn1840-rolling-nda-wilson-disease20261113112544.webp https://www.pharmanow.live/latest-news/kiora-pharmaceuticals-kio-401-ind-pathway-senju-calpain-inhibitor 2026-11-13T11:09:19+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Kiora Pharmaceuticals Advances KIO-401 IND Pathway Kiora https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/kiora-kio-401-rna-calpain-inhibitor-fda-ind-pathway20261113110850.webp https://www.pharmanow.live/latest-news/johnson-johnson-caplyta-phase-3-bipolar-i-mania-second-trial 2026-11-13T11:05:08+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 Johnson & Johnson Secures Second Phase 3 Win for CAPLYTA Johnson & Johnson https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/johnson-johnson-caplyta-phase-3-bipolar-mania-trial20261113110448.webp https://www.pharmanow.live/latest-news/fda-finalizes-gfi-273-durations-of-use-veterinary-antimicrobial-drugs-food-producing-animals 2026-11-13T10:55:33+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 FDA Finalizes GFI 273 on Antimicrobial Use in Food Animals FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-gfi-273-antimicrobial-duration-veterinary-food-producing-animals20261113105253.webp https://www.pharmanow.live/latest-news/proqr-therapeutics-rna-editing-pipeline-phase-1-milestones-h1-2027 2026-11-13T10:45:57+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 ProQR Therapeutics Advances RNA Editing Pipeline ProQR https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/proqr-rna-editing-pipeline-phase-1-h1-2027-milestones20261113104531.webp https://www.pharmanow.live/latest-news/fibrobiologics-expands-fibroblast-ip-portfolio-170-issued-patents 2026-11-13T10:38:35+05:30 Pharma Now en 2026-11-12T00:00:00+05:30 FibroBiologics Expands Patent Portfolio to 170 Issued Patents FibroBiologics https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fibrobiologics-170-issued-patents-fibroblast-therapy-portfolio20261113103650.webp